Clinical trial · Observational
Medial Border of Laparoscopic D3 Lymphadenectomy for Right Colon Cancer
the Medial Border Along the Left Side of SMA Versus the Left Side of SMV in Laparoscopic D3 Lymphadenectomy for Right Colon Cancer, a Prospective Cohort Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): no funds
Summary
Brief summary (as posted)
This study investigats the gastrointestinal functional outcomes of laparoscopic D3 lymphadenectomy for right colon cancer with the medial border along the left side of superior mesenteric artery (SMA) versus the left side of superior mesenteric vein (SMV). This is a single center, prospective cohort study with a sample size of 264 patients. The primary endpoint is the incidence of diarrhea (evaluated using the Diarrhea Assessment Scale) one month after surgery.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colon Cancer | Malignant Colon Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| medial border along the left side of SMA | Procedure | — | UNRESOLVED |
| medial border along the left side of SMV | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- SMA group
- description
- the medial border along the left side of superior mesenteric artery (SMA)
- interventionNames
- Procedure: medial border along the left side of SMA
- label
- SMV group
- description
- the medial border along the left side of superior mesenteric vein (SMV)
- interventionNames
- Procedure: medial border along the left side of SMV
Primary outcomes (1)
- measure
- incidence of diarrhea
- timeFrame
- one month after surgery
- description
- Diarrhea Assessment Scale: stool score ≥ 5
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Age between 18 and 75 years * American Society of Anesthesiologists (ASA) score I to III * A biopsy proven histological diagnosis of colorectal carcinoma * tumor located at right half of colon * Undergoing laparoscopic right hemi-colectomy * preoperative staging cT2-4aN0M0 or cTanyN+M0 * willing to participate and informed consent signed Exclusion Criteria: * Pregnant or lactating women * Synchronous colorectal carcinoma * History of colorectal cancer or other malignant tumors * Clinical evidence of metastasis * Preoperative staging cT1N0 or cT4bNany * Emergency procedure
References
Publications (0)
Data not yet available